Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques.
Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation.
The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 85.0K |
Three Month Average Volume | 3.5M |
High Low | |
Fifty-Two Week High | 10.05 USD |
Fifty-Two Week Low | 0.015 USD |
Fifty-Two Week High Date | 24 Oct 2023 |
Fifty-Two Week Low Date | 08 Aug 2024 |
Price and Volume | |
Current Price | 0.0331 USD |
Beta | 2 |
Relative Price Change | |
Four Week Relative Price Change | -42.68% |
Thirteen Week Relative Price Change | -82.82% |
Twenty-Six Week Relative Price Change | -95.57% |
Fifty-Two Week Relative Price Change | -99.65% |
Year-to-Date Relative Price Change | -97.81% |
Price Change | |
One Day Price Change | -2.65% |
Thirteen Week Price Change | -81.61% |
Twenty-Six Week Price Change | -95.13% |
Five Day Price Change | -8.06% |
Fifty-Two Week Price Change | -99.57% |
Year-to-Date Price Change | -97.40% |
Month-to-Date Price Change | -52.71% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 1.73687 USD |
Book Value Per Share (Most Recent Quarter) | 0.58858 USD |
Tangible Book Value Per Share (Last Fiscal Year) | 1.73687 USD |
Tangible Book Value Per Share (Most Recent Quarter) | 0.58858 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | -3.17251 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 0.39407 USD |
Revenue Per Share (Trailing Twelve Months) | 0.11344 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
Dividend Per Share (Trailing Twelve Months) | 0 USD |
Dividend Per Share (5 Year) | -99999.99 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | -15.89488 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | -12.68056 USD |
Normalized (Last Fiscal Year) | -15.54405 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | -15.89488 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | -12.68056 USD |
Including Extraordinary Items (Last Fiscal Year) | -15.89488 USD |
Including Extraordinary Items (Trailing Twelve Months) | -12.68056 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 3.20483 USD |
Cash Per Share (Most Recent Quarter) | 0.94878 USD |
Cash Flow Per Share (Last Fiscal Year) | -15.33767 USD |
Cash Flow Per Share (Trailing Twelve Months) | -3.52636 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | -2.94182 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | -5,398 |
Cash Flow Revenue (Trailing Twelve Months) | -2,593 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | -3,239.76% |
Pretax Margin (Last Fiscal Year) | -4,033.54% |
Pretax Margin (5 Year) | -6,160.58% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | -78.37% |
Gross Margin (Trailing Twelve Months) | -24.46% |
Gross Margin (5 Year) | -44.53% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | -3,821.63% |
Operating Margin (Trailing Twelve Months) | -3,014.68% |
Operating Margin (5 Year) | -6,017.65% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | -4,033.54% |
Net Profit Margin (Trailing Twelve Months) | -3,239.76% |
Net Profit Margin (5 Year) | -6,160.58% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | -63.25% |
Tangible Book Value (5 Year) | -32.03% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | 14.29% |
Revenue Growth (3 Year) | 54.70% |
Revenue Change (Trailing Twelve Months) | -47.93% |
Revenue Per Share Growth | -11.19% |
Revenue Growth (5 Year) | 48.20% |
Capital Spending Debt | |
Capital Spending (5 Year) | -28.25% |
Total Debt (5 Year) | -99,999.99% |
Dividends | |
Dividend Growth (3 Year) | -99,999.99% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 93.59% |
EPS Change (Trailing Twelve Months) | 83.94% |
EPS Growth (3 Year) | -99,999.99% |
EPS Growth (5 Year) | -99,999.99% |
EBITDA | |
EBITDA (5 Year) | -99,999.99% |
EBITDA (5 Year Interim) | -99,999.99% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -99,999.99% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 0 |
Price to Tangible Book (Most Recent Quarter) | 0 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
Net Debt | |
Net Debt (Most Recent Quarter) | -2,643,000 |
Net Debt (Last Fiscal Year) | -2,686,000 |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 1 |
Price to Sales (Trailing Twelve Months) | 1 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
PE Normalized (Last Fiscal Year) | -100,000 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
Dividends | |
Dividend Yield (5 Year) | -99,999.99% |
Dividend Yield | -99,999.99% |
Current Dividend Yield | 0.00% |
Price to Book | |
Price to Book (Last Fiscal Year) | 0 |
Price to Book (Most Recent Quarter) | 0 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 46 |
Long Term Debt to Equity (Most Recent Quarter) | 22 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | -99,999.99% |
Payout Ratio (Trailing Twelve Months) | -99,999.99% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 2 |
Quick Ratio (Most Recent Quarter) | 2 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 2 |
Current Ratio (Most Recent Quarter) | 2 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | -11,298,000 |
Free Cash Flow (Trailing Twelve Months) | -8,480,000 |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | -18 |
Net Interest Coverage (Trailing Twelve Months) | -13 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 85 |
Total Debt to Equity (Most Recent Quarter) | 75 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | -103.47% |
Return on Assets (Trailing Twelve Months) | -109.80% |
Return on Assets (5 Year) | -80.63% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | -454.34% |
Return on Equity (Trailing Twelve Months) | -1,624.82% |
Return on Equity (5 Year) | -187.28% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | -153.17% |
Return on Investment (Trailing Twelve Months) | -182.50% |
Return on Investment (5 Year) | -112.32% |